Friday, 02 December 2016
  0 Replies
  6.8K Visits

HLN today released a new version of its ICE Open Source Immunization Evaluation and Forecasting software covering the following changes:

HPV updates:

(1) Added support for new 2-dose series; recommend based on 2- or 3-dose series accordingly.

(2) Ignore (HPV, bivalent (Cervarix)) shots administered to males.

(3) Removed minimum age restriction for dose 2 and dose 3

Meningococcal updates:

(1) Added absolute minimum age/minimum age of 16 years for dose 2.

(2) Changed recommended interval between dose 1 and dose 2 from 3 years to 56 days

Please refer to the HPV rules documentation and Meningococcal rules documentation for details.

ICE is a fully Open Source, web-services-based product compliant with US-based ACIP clinical rules. It is fully flexible and could be augmented with other rulesets (like WHO) with appropriate interest, collaboration, and funding. For more information or to join the emerging ICE Open Source Community see the ICE project pageor send email to [email protected].

There are no replies made for this post yet.